| December 2012 | Past Issues | Advertise |
Should You Be Screened for Hepatitis C? Know Your Status Before It is Too Late
Hepatitis C is
sometimes called a "silent killer" because it often has no symptoms and can go
decades without being detected.4 In the meantime, serious liver damage or even
liver cancer may occur.3
Recent studies from the Centers for Disease Control and Prevention (CDC) have reported that deaths from hepatitis C are on the rise. In 2007, there were more than 15,000 deaths in the United States from hepatitis C, surpassing the 13,000 deaths from HIV/AIDS in the same year.5 Baby boomers (born during 1945-1965) have a greater prevalence of hepatitis C than the general population and represent more than 76 percent of all cases of hepatitis C in the United States.6 Moreover, 73 percent of the deaths from hepatitis C occur in this group.5 Those at increased risk for hepatitis C include people who had blood transfusions before 1992, people with tattoos, people who used intravenous drugs – even once – and those who work in a health care setting.3 Certain populations, including African Americans and Hispanics, are also affected by hepatitis C at a significantly higher rate than the general population.7,8 But there is good news. For many patients, hepatitis C can be cured9, unlike other chronic diseases such as hepatitis B and HIV/AIDS. Screening for hepatitis C is not currently part of routine testing; you may think you have been tested, but chances are you haven’t. The CDC recently updated its guidelines recommending that all baby boomers have a simple, one-time antibody test to screen for hepatitis C.6 This new recommendation is to complement the previous screening guidelines based on risk factors, and individuals of all ages with risk factors should still be screened for hepatitis C. According to a CDC-sponsored study, it is estimated that age-based screening of baby boomers could identify more than 800,000 additional cases of chronic hepatitis C infection and, when followed by treatment, could reduce the number of deaths by an additional 121,000 over risk-based screening.10 If you are a baby
boomer or have any risk factors, make sure to ask your doctor for a simple antibody
test to screen for hepatitis C at your next appointment.
For more
information on hepatitis C, visit www.BetterToKnowC.com.
______________________________________
1 Chak, E, et. al. Hepatitis C Virus Infection In USA: An Estimate of True Prevalence. Liver Int. 2011;1096-1098.
2 Colvin HM, Mitchell AE, eds. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Institute of Medicine of the National Academies. Available at: http://www.iom.edu/Reports/2010/Hepatitis-and-Liver-Cancer-A-National-Strategy-for-Prevention-and-Control-of-Hepatitis-B-and-C.aspx. Accessed October 3, 2012.
3 Centers for Disease Control and Prevention. http://www.cdc.gov/hepatitis/C/cFAQ.htm. Accessed October 3, 2012. 4United States Department of Health & Human Services. Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis.http://www.hhs.gov/ash/initiatives/hepatitis/actionplan_viralhepatitis2011.pdf. Accessed October 3, 2012. 5Ly KN, et al. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007. Ann Intern Med. 2012;156:271-278. 6Centers for Disease Control and Prevention. Recommendations for the Identification of Chronic Hepatitis C Infection among Persons Born between 1945-1965. MMWR 2012;61(No. RR-4):1-18. 7Hepatitis C and Latinos. Hepatitis C Support Coalition. 2006. Available at: http://www.hcvadvocate.org/hepatitis/factsheets_pdf/Latinos.pdf. Accessed October 3, 2012. 8Pearlman BL. Hepatitis C in African Americans. Clin Infect Dis. 2006;42:82-91. 9Pearlman BL and Traub N. Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More. Clin Infect Dis. 2011 Apr;52(7):889-900. 10Rein DB, et. al. The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings. Ann Intern Med. 2012; 156:263-270.
|
|
Print this Article 303 Wyman Street, Suite 285, Waltham, MA 02451-1253 |
 |
